TSPO and depressive symptom measurement: Indeed, Richards et al. [165] found that TSPO binding (recall that this is a marker of microglial activation) is highest in patients with depression who are not on antidepressant medication, whereas medicated participants show comparable TSPO binding to undepressed controls.